Jump to content
PathLabTalk

srichar3

Members
  • Content Count

    102
  • Joined

  • Last visited

  • Days Won

    3
  • Country

    United Arab Emirates

srichar3 last won the day on March 14

srichar3 had the most liked content!

Profile Information

  • Gender
    Male
  • Occupation
    Blood Bank Manager

Recent Profile Visitors

1,107 profile views
  1. Chido and Rodgers can be neutralized with Chido/Rodgers positive plasma, what are the antibody characteristics that suggest such an antibody that make you decide to do the antibody neutralization? My understanding is they will be pan-reactive with most if not all identification panel cells and non reactive in enzyme, are there any other characteristics that should lead to the decision to try neutralization or should it be performed on any pan-reactive, non enzyme reactive AB? Thanks
  2. 5.3 Timing of samples The maternal sample for FMH estimation should be taken when sufficient time has elapsed to allow fetal cells to be distributed within the maternal circulation following delivery, manual removal of placenta or sensitising event. A period of 30-45 minutes is considered adequate (BCSH 2006a). BCSH FMH Guidelines 2009
  3. We have a blood transfusion administration module in our HIS, on receipt on the ward they have to scan the unit against the patients electronic record, if it doesn't match the patient it was issued for, it will not allow them to proceed with the administration. I am working to further enhance this by incorporating patient wrist band scan at the same time at the patients bed side.
  4. I want to introduce the Rosette test for FMH screening, unfortunately no commercial kits are available in the UAE where I am based. Right now I cannot even find a Keilhauer staining kit. Does any one use an in house method for this test? if so what Anti-D reagent do you use? AABB have a method which just states high protein Anti-D reagent, can anyone offer any further advice on selecting a suitable Anti-D antisera for use with this method? Thanks
  5. I am looking for a method for performing Hemolysin Titres on blood components, does anyone have one they would be willing to share? Thanks
  6. The thirty year rule came from the European blood directive 2002/98/EC, the NHS is only UK based, this was a European wide requirement. https://www.health-ni.gov.uk/articles/blood-safety-and-quality-regulations-2005-amended#:~:text=The Regulations,-The retention periods&text=Blood establishments and hospital blood,(regulations 8 and 9). Also there is no such 30 year limit on suing the NHS, its 3 years from the date of discovery, so if you didn't find out until 50 years later then it would be 53 years. Applicable Time Limits To Sue The NHS Claimant immediat
  7. Wasn't 30 years due to vCJD risk? as the incubation period can be 20 years+ hence records need to be kept this long at least for tracing potential donor and other recipients from same donor? With regards to record keeping, in my experience in the UK while we kept the administration record of the anti-D the same as we did for all blood components/products, 30 years. Once we were satisfied that the anti-D was not of immune origin we would remove the record from the antibody file otherwise we would not be able to use electronic issue for future crossmatches. Our LIS was such though that it
  8. And also my reason for asking which antigens are most likely, so I know which ones to try first rather than ordering them all.
  9. I'm looking into sourcing these from a company in Germany called inno-train who provide molecular blood typing products also, I believe from the name in the IFU's provided these are the same (imusyn GmbH & Co. KG.) that you mention above. My next question was going to be if anyone has any feedback on these techniques? imusyn rBGA Kits_v19_EN_RUO.pdf
  10. Column agglutination with glass beads instead of Gel from Ortho.
  11. We run auto control with all our panels and in these cases they are negative, were a women's speciality hospital in the middle east. I'm literally getting 3 or 4 of these a week and we have no reference service so mostly they are going unidentified. I'm trying to develop our identification protocols and source additional reagents to help ID these cases but struggling to find HFA negative cells out here. Just to add in most cases these are pregnant women.
  12. We receive a lot of antibody screens that tend to be positive in all screening cells, both with or without enzyme reactivity. In such cases what are the most likely culprits?
  13. Is there any Alinity HQ users who have results evaluation report for CAP survey FH9-B who would be willing to share a copy of the report? we are evaluating Alinity HQ and want to Alinity group means. Thanks
  14. Yes from the UK originally but now working in the UAE where we follow AABB and CAP standards. Are you from the UK also?
  15. In the UK its common practice, every hospital I have worked at follow this practice, it is strictly for life and death emergencies where there simply isn't time to lease with the blood bank. I haven't seen anything in the CAP or AABB standards regarding it that's why I was asking, I guess under US regulations/practices this isn't a followed practice then. Regarding the vending machines these are more a sort of remote electronic crossmatch than emergency O neg I believe.
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.